Combination Paclitaxel, Carboplatin, and Gemcitabine Is an Active Treatment for Advanced Urothelial Cancer
- 1 May 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (9) , 2527-2533
- https://doi.org/10.1200/jco.2001.19.9.2527
Abstract
PURPOSE: To determine the efficacy and toxicity of the drug combination of carboplatin, paclitaxel, and gemcitabine in patients with advanced urothelial carcinoma. PATIENTS AND METHODS: Patients el...Keywords
This publication has 24 references indexed in Scilit:
- Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.British Journal of Cancer, 1998
- Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma.Journal of Clinical Oncology, 1998
- Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen.Journal of Clinical Oncology, 1998
- Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.Journal of Clinical Oncology, 1997
- Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.Journal of Clinical Oncology, 1997
- Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1997
- Carboplatin-based chemotherapy for bladder cancerCancer Treatment Reviews, 1993
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Journal of Clinical Oncology, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989